179 related articles for article (PubMed ID: 33713651)
1. Transgenic pyrimethamine-resistant plasmodium falciparum reveals transmission-blocking potency of P218, a novel antifolate candidate drug.
Posayapisit N; Pengon J; Prommana P; Shoram M; Yuthavong Y; Uthaipibull C; Kamchonwongpaisan S; Jupatanakul N
Int J Parasitol; 2021 Jul; 51(8):635-642. PubMed ID: 33713651
[TBL] [Abstract][Full Text] [Related]
2. New Insights into Antimalarial Chemopreventive Activity of Antifolates.
Pethrak C; Posayapisit N; Pengon J; Suwanakitti N; Saeung A; Shorum M; Aupalee K; Taai K; Yuthavong Y; Kamchonwongpaisan S; Jupatanakul N
Antimicrob Agents Chemother; 2022 Feb; 66(2):e0153821. PubMed ID: 34930029
[TBL] [Abstract][Full Text] [Related]
3. Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil.
Basco LK; Ringwald P
Am J Trop Med Hyg; 2000 Feb; 62(2):271-6. PubMed ID: 10813484
[TBL] [Abstract][Full Text] [Related]
4. Pyrimethamine analogs as strong inhibitors of double and quadruple mutants of dihydrofolate reductase in human malaria parasites.
Sardarian A; Douglas KT; Read M; Sims PF; Hyde JE; Chitnumsub P; Sirawaraporn R; Sirawaraporn W
Org Biomol Chem; 2003 Mar; 1(6):960-4. PubMed ID: 12929634
[TBL] [Abstract][Full Text] [Related]
5. Selection of drug resistant mutants from random library of Plasmodium falciparum dihydrofolate reductase in Plasmodium berghei model.
Tipsuwan W; Srichairatanakool S; Kamchonwongpaisan S; Yuthavong Y; Uthaipibull C
Malar J; 2011 May; 10():119. PubMed ID: 21554743
[TBL] [Abstract][Full Text] [Related]
6. Molecular epidemiology of malaria in Cameroon. XXVII. Clinical and parasitological response to sulfadoxine-pyrimethamine treatment and Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase alleles in Cameroonian children.
Tahar R; Basco LK
Acta Trop; 2007 Aug; 103(2):81-9. PubMed ID: 17640607
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of Southeast Asian Plasmodium falciparum isolates to P218.
Posayapisit N; Pengon J; Shaw PJ; Uthaipibull C; Kongkasuriyachai D; Phyo AP; Nosten F; Yuthavong Y; Kamchonwongpaisan S
Int J Antimicrob Agents; 2023 Jul; 62(1):106838. PubMed ID: 37160237
[TBL] [Abstract][Full Text] [Related]
8. Decreased Susceptibility to Dihydrofolate Reductase Inhibitors Associated With Genetic Polymorphisms in Ugandan Plasmodium falciparum Isolates.
Kreutzfeld O; Tumwebaze PK; Byaruhanga O; Katairo T; Okitwi M; Orena S; Rasmussen SA; Legac J; Conrad MD; Nsobya SL; Aydemir O; Bailey JA; Duffey M; Cooper RA; Rosenthal PJ
J Infect Dis; 2022 Feb; 225(4):696-704. PubMed ID: 34460932
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors of multiple mutants of Plasmodium falciparum dihydrofolate reductase and their antimalarial activities.
Kamchonwongpaisan S; Quarrell R; Charoensetakul N; Ponsinet R; Vilaivan T; Vanichtanankul J; Tarnchompoo B; Sirawaraporn W; Lowe G; Yuthavong Y
J Med Chem; 2004 Jan; 47(3):673-80. PubMed ID: 14736247
[TBL] [Abstract][Full Text] [Related]
10. Rational drug design approach for overcoming drug resistance: application to pyrimethamine resistance in malaria.
McKie JH; Douglas KT; Chan C; Roser SA; Yates R; Read M; Hyde JE; Dascombe MJ; Yuthavong Y; Sirawaraporn W
J Med Chem; 1998 Apr; 41(9):1367-70. PubMed ID: 9554869
[TBL] [Abstract][Full Text] [Related]
11. Short communication: Prevalence of mutations associated with resistance to atovaquone and to the antifolate effect of proguanil in Plasmodium falciparum isolates from northern Ghana.
Muehlen M; Schreiber J; Ehrhardt S; Otchwemah R; Jelinek T; Bienzle U; Mockenhaupt FP
Trop Med Int Health; 2004 Mar; 9(3):361-3. PubMed ID: 14996365
[TBL] [Abstract][Full Text] [Related]
12. Similar trends of pyrimethamine resistance-associated mutations in Plasmodium vivax and P. falciparum.
Alam MT; Bora H; Bharti PK; Saifi MA; Das MK; Dev V; Kumar A; Singh N; Dash AP; Das B; Wajihullah ; Sharma YD
Antimicrob Agents Chemother; 2007 Mar; 51(3):857-63. PubMed ID: 17194833
[TBL] [Abstract][Full Text] [Related]
13. Surveillance of molecular markers for antimalarial resistance in Zambia: Polymorphism of Pfkelch 13, Pfmdr1 and Pfdhfr/Pfdhps genes.
Sitali L; Mwenda MC; Miller JM; Bridges DJ; Hawela MB; Hamainza B; Mudenda-Chilufya M; Chizema-Kawesha E; Daniels RF; Eisele TP; Nerland AH; Chipeta J; Lindtjorn B
Acta Trop; 2020 Dec; 212():105704. PubMed ID: 33002448
[TBL] [Abstract][Full Text] [Related]
14.
Torrevillas BK; Garrison SM; McKeeken AJ; Patel D; Van Leuven JT; Dizon NI; Rivas KI; Hathaway NJ; Bailey JA; Waitumbi JN; Kifude CM; Oyieko J; Stewart VA; Luckhart S
Front Cell Infect Microbiol; 2020; 10():600112. PubMed ID: 33324580
[TBL] [Abstract][Full Text] [Related]
15. Plasmodium falciparum dihydrofolate reductase Val-16 and Thr-108 mutation associated with in vivo resistance to antifolate drug: a case study.
Biswas S
Indian J Malariol; 2001; 38(3-4):76-83. PubMed ID: 12125519
[TBL] [Abstract][Full Text] [Related]
16. Antifolate drug resistance and point mutations in Plasmodium falciparum in Kenya.
Khan B; Omar S; Kanyara JN; Warren-Perry M; Nyalwidhe J; Peterson DS; Wellems T; Kaniaru S; Gitonga J; Mulaa FJ; Koech DK
Trans R Soc Trop Med Hyg; 1997; 91(4):456-60. PubMed ID: 9373654
[TBL] [Abstract][Full Text] [Related]
17. Selection of antifolate-resistant Plasmodium falciparum by sulfadoxine-pyrimethamine treatment and infectivity to Anopheles mosquitoes.
Méndez F; Herrera S; Murrain B; Gutiérrez A; Moreno LA; Manzano M; Muñoz A; Plowe CV
Am J Trop Med Hyg; 2007 Sep; 77(3):438-43. PubMed ID: 17827356
[TBL] [Abstract][Full Text] [Related]
18. Mutagenesis of dihydrofolate reductase from Plasmodium falciparum: analysis in Saccharomyces cerevisiae of triple mutant alleles resistant to pyrimethamine or WR99210.
Ferlan JT; Mookherjee S; Okezie IN; Fulgence L; Sibley CH
Mol Biochem Parasitol; 2001 Mar; 113(1):139-50. PubMed ID: 11254962
[TBL] [Abstract][Full Text] [Related]
19. Malaria antifolate resistance with contrasting Plasmodium falciparum dihydrofolate reductase (DHFR) polymorphisms in humans and Anopheles mosquitoes.
Mharakurwa S; Kumwenda T; Mkulama MA; Musapa M; Chishimba S; Shiff CJ; Sullivan DJ; Thuma PE; Liu K; Agre P
Proc Natl Acad Sci U S A; 2011 Nov; 108(46):18796-801. PubMed ID: 22065788
[TBL] [Abstract][Full Text] [Related]
20. Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase.
Sirawaraporn W; Sathitkul T; Sirawaraporn R; Yuthavong Y; Santi DV
Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1124-9. PubMed ID: 9037017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]